Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).